Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb Co shares valued at $2,650,480 were sold by Elkins David V on Sep 02 ’25. At $47.33 per share, Elkins David V sold 56,000 shares. The insider’s holdings dropped to 167,379 shares worth approximately $9.54 million following the completion of this transaction.
Also, Elkins David V purchased 56,000 shares, netting a total of over 2,648,800 in proceeds.
Before that, Short Bartie Wendy had sold 378 shares from its account. In a trade valued at $16,719, the EVP, Corporate Affairs traded Bristol-Myers Squibb Co shares for $44.23 each. Upon closing the transaction, the insider’s holdings decreased to 378 shares, worth approximately $0.29 million.
As published in a research note from UBS on January 07, 2026, Bristol-Myers Squibb Co [BMY] has been rated up from a Neutral to a Buy and the price target has been revised to $65. Analysts at BofA Securities upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in mid December. As of December 12, 2025, Guggenheim has increased its “Neutral” rating to a “Buy” for BMY. Earlier on November 13, 2025, Scotiabank initiated its rating. Their recommendation was “a Sector perform” for BMY stock.
Analyzing BMY Stock Performance
On last trading session, Bristol-Myers Squibb Co [NYSE: BMY] rose 1.97% to $57.02. The stock’s lowest price that day was $55.73, but it reached a high of $57.04 in the same session. During the last five days, there has been a surge of approximately 0.53%. Over the course of the year, Bristol-Myers Squibb Co shares have jumped approximately 3.00%.
Is Bristol-Myers Squibb Co subject to short interest?
Stocks of Bristol-Myers Squibb Co saw a sharp rise in short interest on 2025-12-31 jumping by 2.69 million shares to 36.58 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 33.89 million shares. A jump of 7.35% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.25 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.25.
Which companies own the most shares of Bristol-Myers Squibb Co (BMY)?
In terms of Bristol-Myers Squibb Co share price expectations, FactSet research, analysts set an average price target of 60 in the next 12 months, up nearly 7.3% from the previous closing price of $55.92. Analysts anticipate Bristol-Myers Squibb Co stock to reach 65 by 2026, with the lowest price target being 37. In spite of this, 14 analysts ranked Bristol-Myers Squibb Co stock as Hold at the end of 2026. On August 05, 2025, Daiwa Securities assigned a price target of “a Neutral” to the stock and downgraded coverage with a $42.
